Buy Dermovate (Clobetasol Proportionate)


Active substance: Clobetasol Proportionate 0.05%

Without prescription
1 tube x 25ml


Dermovate (also known by its active substance Clobetasol propotionate) is cream or ointment used to cure inflammatory skin issues such as psoriasis, eczema, and dermatits. It helps reducing inflamation, itchiness, and redness of the skin.
When purchasing Dermovate online, it is important to order from reputable sources to guarantee the purchase of a genuine product at a fair price.
The usage of Dermovate is determined by the severity and the location of the skin problem being treated. Typically, a thin layer of Dermoveyt should be applied to the skin twice a day. It is not recommended to use Dermovate for more than 14 days without medical supervision.
Dermovate can have side effects, such as thinning of the skin, striae, and telangiectasia. The risk of side effects increases with prolonged use, on large areas of skin, or with occlusive dressings.
Do not use Dermovate if you are allergic to any of the ingredients, have viral, bacterial, or fungal skin infections. Also, do not apply Dermovate to areas of the skin that have been treated with radiation therapy, and people with rosacea, acne or perioral dermatitis should not use it either.
In conclusion: Dermovate can effectively cure inflammatory skin problems. It is important to be aware of potential side effects and contraindications before using the cream or ointment. Order Dermovate online from a reputable source to ensure quality and a fair price.

Method of application and dosage

Externally. Applying the cream is especially useful on damp or wet surfaces. The drug is applied 1-2 times a day in a thin layer not exceeding the amount needed to cover the entire affected area and rubbed in gently. Duration of use – until the start of the action, or in some cases up to 4 weeks. Treatment can be done within 4 weeks. If longer treatment is required, the frequency of application should be gradually reduced or less active drugs should be used. After applying Dermovate®, allow sufficient time for absorption before applying emollient. Short (intermittent) courses of Dermovate® are administered to prevent exacerbation of skin conditions. In particularly resistant cases, especially in the presence of keratosis, the effectiveness of Dermovate® can be enhanced by applying an occlusive dressing (PE film) nightly to the area of ​​application. This is usually accompanied by dynamic positive symptoms. The effect achieved can usually be maintained in the future without the use of occlusive dressings. If the condition worsens or does not improve within 2-4 weeks, the diagnosis and treatment should be reconsidered. Maximum dose should not exceed 50 g/week. Once the atopic dermatitis (eczema) disease is under control, treatment with Dermovate should be discontinued gradually and treatment with emollients should be continued as maintenance therapy. Abrupt discontinuation of Dermovate® may lead to recurrence of pre-existing skin conditions. Patients with eczema (persistent course) with frequent recurrences of the disease. For acute illness, intermittent use (once daily, twice weekly, without occlusive dressings) can be considered if continued treatment with topical corticosteroids is effective. This treatment has been shown to be effective in reducing recurrence rates. Drug use should be continued on all previously affected skin areas or areas of known potential for deterioration. This regime should be combined with regular daily use of emollients. Regular assessment of the condition and the benefits and risks of continuing treatment should be performed. Children of special patient groups. Children are more likely to develop local and systemic side effects from topical corticosteroids and generally require fewer active ingredients and shorter durations of treatment than adults. When using Dermovate® in children, be careful to use the lowest therapeutically effective dose. elderly patients. Clinical studies have not shown differences in drug efficacy in older and younger patients. The high prevalence of hepatic or renal dysfunction in elderly patients may slow drug elimination by systemic absorption. Therefore, it should be used in elderly patients at minimal doses and for as short a time as possible while still achieving the desired clinical effect. Impaired kidney and/or liver function. If a drug is systemically absorbed (applied to large areas of the skin for a long period of time), its metabolism and excretion may be slowed, increasing the risk of systemic toxicity. Therefore, in such patients, it should be used in the lowest possible dose and for the shortest possible time while still achieving the desired clinical effect.

Anti-inflammatory agent with glucocorticoid activity.
Active ingredient: clobetasol propionate 50 mg
Excipients: glyceryl monostearate – 11 g, propylene glycol glyceryl oleate (arlacel 165) – 1.5 g, beeswax substitute 6621 – 1.25 g, cetostearyl alcohol – 8.4 g, propylene glycol – 47.5 g, chlorocresol – 75 mg, sodium citrate – 50 mg, citric acid monohydrate – 50 mg, purified water – up to 100 g.
Pharmacotherapeutic group
0010 Glucocorticosteroids
Dermovate® is a highly active topical corticosteroid indicated for use in adults, the elderly and children over 1 year of age to relieve the symptoms of inflammation and pruritus in dermatoses sensitive to corticosteroid therapy: psoriasis (excluding widespread plaque psoriasis); eczema (various forms); lichen planus; discoid lupus erythematosus; dermatoses resistant to therapy with less active corticosteroids for external use. Since the drug in the form of an ointment helps to retain moisture in the skin, it is recommended to use Dermovate® topical ointment for skin lesions accompanied by dryness, hyperkeratosis and thickening.
hypersensitivity to the active and excipients of the drug; bacterial, viral and fungal skin diseases (including herpes simplex, chicken pox, skin tuberculosis, actinomycosis); rosacea (rosacea); acne skin cancer; knotty pruritus Hyde; perioral dermatitis; pruritus in the absence of inflammation; perianal and genital itching; widespread plaque psoriasis; lactation period; age up to 1 year. With caution: pregnancy.
Side effect
The adverse events presented below are listed depending on the anatomical and physiological classification and frequency of occurrence. The frequency of occurrence is defined as follows: very often (≥1/10); often (≥1/100 and <1/10); infrequently (≥1/1000 and <1/100); rarely (≥1/10000 and <1/1000); very rarely (<1/10000, including isolated cases). Frequency categories were formed on the basis of clinical trials of the drug and post-marketing surveillance. Infectious and parasitic diseases: very rarely – an infection caused by opportunistic pathogens. From the immune system: very rarely – hypersensitivity. From the endocrine system: very rarely – depression of the hypothalamic-pituitary-adrenal system, signs of cushingoid (moon face, central obesity), delayed weight gain and / or growth retardation in children, osteoporosis, glaucoma, hyperglycemia and / or glucosuria, cataracts , hypertension, weight gain or obesity, decreased endogenous cortisol levels, alopecia, brittle hair. From the skin and subcutaneous tissues: often – itching, burning sensation or soreness; infrequently – local skin atrophy*, striae*, telangiectasia*; very rarely – thinning *, wrinkling of the skin, dry skin *, pigmentation changes *, hypertrichosis, aggravation of symptoms of the disease, allergic contact dermatitis, pustular psoriasis, erythema, rash, urticaria. General disorders and disorders at the injection site: very rarely – irritation and / or soreness at the application site. * Skin manifestations are secondary to local and/or systemic effects of depression of the hypothalamic-pituitary-adrenal system. When applied to large surfaces for a long period of time (for example, more than 2 weeks), patients may develop systemic side effects: gastritis, ulceration of the gastrointestinal mucosa, increased IOP, symptoms of hypercortisolism.
Storage conditions
At temperatures up to 30 °C
Best before date
2 years

Dermovate for sale: Even if a prescription is not required, it is assumed that you have a valid prescription or doctor’s recommendation. Please do not self-cure. Get expert advice before purchasing Dermovate (Clobetasol Proportionate) online.

The drug images are for illustrative purposes only and may differ from the actual product.

The product is intended for the Russian market and can be labeled in Russian (Packaging design may vary). To make sure that you are buying the right product, just translate the word Дермовейт into English using Google Translate. Just copy it and paste.



There are no reviews yet.

Be the first to review “DERMOVATE CREAM 25 ml”

Your email address will not be published. Required fields are marked *

Shopping Cart